
Results
4
Big ticket companies showing a potential underpricing based on intrinsic value
4 companies
AstraZeneca
Market Cap: UK£178.4b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£117.40
7D
-9.3%
1Y
4.6%
GSK
Market Cap: UK£76.5b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.15
7D
-5.6%
1Y
37.0%
Haleon
Market Cap: UK£31.9b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.58
7D
-6.1%
1Y
2.3%
Hikma Pharmaceuticals
Market Cap: UK£3.3b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£15.81
7D
-2.0%
1Y
-17.5%